
Aanvi Pharmaceuticals Private Limited
About Aanvi Pharmaceuticals Private Limited
Data last updated:
Aanvi Pharmaceuticals Private Limited is a private limited company based in Barnala, Punjab, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 15 June 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230PB2009PTC032922. Its GSTIN is 03AAHCA7592B1ZW (Punjab).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neel Kanth (Whole-Time Director) and Rajni Sharma.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 210 Mahesh Nagar Handiaya Road, Barnala, Punjab, India – 148101.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.68 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹17,449 (net margin 0.6%) and EBITDA of ₹1.69 Lakh (EBITDA margin 5.3%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 7% over five years.
As per MCA filings, the company has open charges of ₹8 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aanvi Pharmaceuticals Private Limited's registered office is in Barnala, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 210 Mahesh Nagar Handiaya Road, Barnala, Punjab, India – 148101
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Aanvi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aanvi Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aanvi Pharmaceuticals Private Limited, buy the company report.
Financials of Aanvi Pharmaceuticals Private Limited
FY 2025 filings availableAanvi Pharmaceuticals Private Limited reported revenue of ₹31.68 Lakh (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 7% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17,449 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aanvi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aanvi Pharmaceuticals Private Limited
Aanvi Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajni Sharma Also directs: Vanachem Pharma Private Limited | Director | 15 Jun 2009 | 17 Years 5 Months | Current |
| Neel Kanth Also directs: Vanachem Pharma Private Limited | Whole-Time Director | 15 Jun 2009 | 17 Years 5 Months | Current |
Peer comparison
Aanvi Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Venetic Pharmaceuticals Private Limited | ₹31.85 Lakh (FY 2025) | 23.0% | Patna, Bihar, India | |||
| Remission Pharmaceuticals Private Limited | ₹31.83 Lakh (FY 2025) | 145.0% | Hyderabad, Telangana, India | |||
| Welltech Pharmaceuticals Private Limited | ₹31.81 Lakh (FY 2025) | 11.0% | Delhi, India | |||
| Armiya Pharmaceuticals Private Limited | ₹31.69 Lakh (FY 2025) | 0.0% | Bareilly, Uttar Pradesh, India | |||
| Aanvi Pharmaceuticals Private Limitedthis company | ₹31.68 Lakh (FY 2025) | ₹17,449 | 0.6% | 7.0% | Barnala, Punjab, India | |
| Zovalta Pharmaceuticals Private Limited | ₹31.6 Lakh (FY 2021) | -27.0% | Hyderabad, Telangana, India | |||
| VDV Pharmaceuticals Private Limited | ₹31.57 Lakh (FY 2025) | -80.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Aanvi Pharmaceuticals Private Limited, buy the company report.
Auditor
Aanvi Pharmaceuticals Private Limited is audited by BISHNOI & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BISHNOI & ASSOCIATES | FY 2017 | 019929N |
Shareholding
The shareholding of Aanvi Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aanvi Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jun 2014 | 10505800 | State Bank of India | ₹8 Lakh | Open |
To see the full charge records of Aanvi Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Aanvi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aanvi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aanvi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAHCA7592B1ZW | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aanvi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aanvi Pharmaceuticals Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Neel Kanth was appointed as Whole-Time Director on 15 Jun 2009.
Frequently asked questions
Aanvi Pharmaceuticals is an active private limited company based in Barnala, Punjab, India. The company works in other wholesale, within the trading industry. It was incorporated on 15 June 2009 (17+ years old) and is registered under CIN U24230PB2009PTC032922.
Aanvi Pharmaceuticals has 2 current directors:
- Neel Kanth - Whole-Time Director
- Rajni Sharma - Director
The latest financial statements of Aanvi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aanvi Pharmaceuticals is 03AAHCA7592B1ZW, registered in Punjab.
The CIN (Corporate Identification Number) of Aanvi Pharmaceuticals is U24230PB2009PTC032922. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aanvi Pharmaceuticals was incorporated on 15 June 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Aanvi Pharmaceuticals by revenue are Venetic Pharmaceuticals Private Limited, Remission Pharmaceuticals Private Limited, Welltech Pharmaceuticals Private Limited, Armiya Pharmaceuticals Private Limited, Zovalta Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Neel Kanth was appointed as Whole-Time Director on 15 Jun 2009. Rajni Sharma was appointed as Director on 15 Jun 2009.
The registered office of Aanvi Pharmaceuticals is at Plot No. 210 Mahesh Nagar Handiaya Road, Barnala, Punjab, India – 148101.
Aanvi Pharmaceuticals operates in the trading industry, in the other wholesale segment.
Aanvi Pharmaceuticals has open charges of ₹8 Lakh and no satisfied charges on record as per latest MCA filings.

